Literature DB >> 23271160

Recurrent herpetic stromal keratitis in mice, a model for studying human HSK.

Jessica Morris1, Patrick M Stuart, Megan Rogge, Chloe Potter, Nipun Gupta, Xiao-Tang Yin.   

Abstract

Herpetic eye disease, termed herpetic stromal keratitis (HSK), is a potentially blinding infection of the cornea that results in over 300,000 clinical visits each year for treatment. Between 1 and 2 percent of those patients with clinical disease will experience loss of vision of the infected cornea. The vast majority of these cases are the result of reactivation of a latent infection by herpes simplex type I virus and not due to acute disease. Interestingly, the acute infection is the model most often used to study this disease. However, it was felt that a recurrent model of HSK would be more reflective of what occurs during clinical disease. The recurrent animal models for HSK have employed both rabbits and mice. The advantage of rabbits is that they experience reactivation from latency absent any known stimulus. That said, it is difficult to explore the role that many immunological factors play in recurrent HSK because the rabbit model does not have the immunological and genetic resources that the mouse has. We chose to use the mouse model for recurrent HSK because it has the advantage of there being many resources available and also we know when reactivation will occur because reactivation is induced by exposure to UV-B light. Thus far, this model has allowed those laboratories using it to define several immunological factors that are important to this disease. It has also allowed us to test both therapeutic and vaccine efficacy.

Entities:  

Mesh:

Year:  2012        PMID: 23271160      PMCID: PMC3576418          DOI: 10.3791/4276

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  15 in total

1.  IL-1 and TNF-alpha are important factors in the pathogenesis of murine recurrent herpetic stromal keratitis.

Authors:  T L Keadle; N Usui; K A Laycock; J K Miller; J S Pepose; P M Stuart
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-01       Impact factor: 4.799

2.  Therapeutic immunization with a virion host shutoff-defective, replication-incompetent herpes simplex virus type 1 strain limits recurrent herpetic ocular infection.

Authors:  Tammie L Keadle; Lynda A Morrison; Jessica L Morris; Jay S Pepose; Patrick M Stuart
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

3.  Efficacy of a recombinant glycoprotein D subunit vaccine on the development of primary and recurrent ocular infection with herpes simplex virus type 1 in mice.

Authors:  T L Keadle; K A Laycock; J K Miller; K K Hook; E D Fenoglio; M Francotte; M Slaoui; P M Stuart; J S Pepose
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

4.  Reactivation of latent infection and induction of recurrent herpetic eye disease in mice.

Authors:  C Shimeld; T J Hill; W A Blyth; D L Easty
Journal:  J Gen Virol       Date:  1990-02       Impact factor: 3.891

5.  Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system.

Authors:  C Shimeld; T J Hill; W A Blyth; D L Easty
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

6.  An improved model of recurrent herpetic eye disease in mice.

Authors:  C Shimeld; T Hill; B Blyth; D Easty
Journal:  Curr Eye Res       Date:  1989-11       Impact factor: 2.424

7.  Therapeutic vaccination with vhs(-) herpes simplex virus reduces the severity of recurrent herpetic stromal keratitis in mice.

Authors:  Tammie L Keadle; Keith A Laycock; Jessica L Morris; David A Leib; Lynda A Morrison; Jay S Pepose; Patrick M Stuart
Journal:  J Gen Virol       Date:  2002-10       Impact factor: 3.891

8.  Delivery of Interferon-gamma by an adenovirus vector blocks herpes simplex virus Type 1 reactivation in vitro and in vivo independent of RNase L and double-stranded RNA-dependent protein kinase pathways.

Authors:  Daniel J J Carr; Bobbie A Austin; William P Halford; Patrick M Stuart
Journal:  J Neuroimmunol       Date:  2008-11-29       Impact factor: 3.478

9.  CD4(+) and CD8(+) cells are key participants in the development of recurrent herpetic stromal keratitis in mice.

Authors:  T L Keadle; J L Morris; J S Pepose; P M Stuart
Journal:  Microb Pathog       Date:  2002-06       Impact factor: 3.738

10.  Characterization of a murine model of recurrent herpes simplex viral keratitis induced by ultraviolet B radiation.

Authors:  K A Laycock; S F Lee; R H Brady; J S Pepose
Journal:  Invest Ophthalmol Vis Sci       Date:  1991-09       Impact factor: 4.799

View more
  8 in total

1.  Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation.

Authors:  Lbachir BenMohamed; Nelson Osorio; Ruchi Srivastava; Arif A Khan; Jennifer L Simpson; Steven L Wechsler
Journal:  J Neurovirol       Date:  2015-05-22       Impact factor: 2.643

2.  The evaluation of diagnostic efficiency for stromal herpes simplex keratitis by the combination of tear HSV-sIgA and HSV-DNA.

Authors:  Jini Qiu; Feifei Huang; Zhujian Wang; Jianjiang Xu; Chaoran Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-27       Impact factor: 3.117

3.  Real-time polymerase chain reaction for the diagnosis of necrotizing herpes stromal keratitis.

Authors:  Jun-Xin Ma; Lin-Nong Wang; Ru-Xia Zhou; Yang Yu; Tong-Xin Du
Journal:  Int J Ophthalmol       Date:  2016-05-18       Impact factor: 1.779

4.  Prior Corneal Scarification and Injection of Immune Serum are Not Required Before Ocular HSV-1 Infection for UV-B-Induced Virus Reactivation and Recurrent Herpetic Corneal Disease in Latently Infected Mice.

Authors:  Lbachir BenMohamed; Nelson Osorio; Arif A Khan; Ruchi Srivastava; Lei Huang; John J Krochmal; Jairo M Garcia; Jennifer L Simpson; Steven L Wechsler
Journal:  Curr Eye Res       Date:  2015-09-23       Impact factor: 2.424

5.  Bolstering the Number and Function of HSV-1-Specific CD8+ Effector Memory T Cells and Tissue-Resident Memory T Cells in Latently Infected Trigeminal Ganglia Reduces Recurrent Ocular Herpes Infection and Disease.

Authors:  Arif A Khan; Ruchi Srivastava; Aziz A Chentoufi; Elizabeth Kritzer; Sravya Chilukuri; Sumit Garg; David C Yu; Hawa Vahed; Lei Huang; Sabrina A Syed; Julie N Furness; Tien T Tran; Nesburn B Anthony; Christine E McLaren; John Sidney; Alessandro Sette; Randolph J Noelle; Lbachir BenMohamed
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

6.  CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.

Authors:  Ruchi Srivastava; Arif A Khan; Sravya Chilukuri; Sabrina A Syed; Tien T Tran; Julie Furness; Elmostafa Bahraoui; Lbachir BenMohamed
Journal:  J Virol       Date:  2017-06-26       Impact factor: 5.103

7.  The Characteristics of Herpes Simplex Virus Type 1 Infection in Rhesus Macaques and the Associated Pathological Features.

Authors:  Shengtao Fan; Hongzhi Cai; Xingli Xu; Min Feng; Lichun Wang; Yun Liao; Ying Zhang; Zhanlong He; Fengmei Yang; Wenhai Yu; Jingjing Wang; Jumin Zhou; Qihan Li
Journal:  Viruses       Date:  2017-01-30       Impact factor: 5.048

8.  Inhibitory effects of baicalein against herpes simplex virus type 1.

Authors:  Zhuo Luo; Xiu-Ping Kuang; Qing-Qing Zhou; Chang-Yu Yan; Wen Li; Hai-Biao Gong; Hiroshi Kurihara; Wei-Xi Li; Yi-Fang Li; Rong-Rong He
Journal:  Acta Pharm Sin B       Date:  2020-06-25       Impact factor: 11.413

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.